Boucher Kelley
SEC insider (Form 3/4/5 filer). CIK 0002070437. Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS). 13 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies Boucher Kelley has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief People Officer
Boucher Kelley
CIK: 0002070437
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect30.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect127.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect15.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect15.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect30.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect30.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect22.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect45.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect30.5K shares- - Jan 28, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect30.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 30,146 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 127,804 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 15,073 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 15,073 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 30,146 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 30,146 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 22,087 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 45,095 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 30,476 | - | $0 | Direct |
| Jan 28, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 30,146 | - | $0 | Direct |
1-10 of 13 transactions